Announcements Trials

Browse Landscape Eligibility

Clinical Trials

2 trials

Recent Start date Enrollment

Pruritus × masitinib × Myeloid × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 2

Sponsor

Cancer Type

Conditions

Mastocytosis 4 Pruritus 2 Piebaldism 2 Mastocytosis, Systemic 2 Blushing 2

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04333108 2023-05-06

Masitinib in Severe Indolent or Smoldering Systemic Mastocytosis Unresponsive to Optimal Symptomatic Treatment

AB Science

Phase 3 Unknown

Blushing, Mastocytosis, Pruritus, Piebaldism, Mastocytosis, Systemic

NCT00814073 2019-12-03

AB06006

AB Science

Phase 3 Completed

Blushing, Mastocytosis, Pruritus, Piebaldism, Mastocytosis, Systemic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡